Previous 10 | Next 10 |
MENLO PARK, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2023 financial results and provide a corporate update on February 15, 2024. The company will also host a conference call that day at 5...
MENLO PARK, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the...
MENLO PARK, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...
2024-01-06 10:13:00 ET Summary I have a total of 41 positions in my closed-end fund portfolio, with the top ten positions making up 36.52% of the portfolio. We have four new names making their way to my top ten list since the prior update, but three were already positions that hav...
2024-01-02 21:31:55 ET Summary Total Return is the actual rate of return for an investment over a given evaluation period, typically one, three, five, or ten years. The Total NAV Return is the sum of all dividends/distributions, assuming they are reinvested, plus the change in the...
MENLO PARK, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating the effects of the horm...
2023-12-15 04:38:41 ET John Hancock Financial Opportunities Fund ( NYSE: BTO ), John Hancock Hedged Equity & Income Fund ( NYSE: HEQ ), John Hancock Income Securities Trust ( NYSE: JHS ), John Hancock Investors Trust ( NYSE: JHI ), John Hancock Premium ...
2023-12-13 05:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-28 07:26:26 ET Summary John Hancock Premium Dividend Fund cut its distribution earlier this year, leading to a sell-off, but the discount/premiums of closed-end funds can be exploited by investors. PDT's discount has narrowed since the distribution cut pushed it to a wide ...
2023-11-07 07:55:10 ET Summary The John Hancock Tax-Advantaged Dividend Income Fund aims to provide high current income and capital gains through investments in common equity. The fund has underperformed the S&P 500 Index over the past two months but has only lost 5.14% for in...
News, Short Squeeze, Breakout and More Instantly...
John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
HTD Stock Symbol:
NYSE Market:
MENLO PARK, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of t...
MENLO PARK, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of th...
2024-04-09 09:00:15 ET John Hancock Tax- Advantaged Dividend Income (HTD) declaring a stock dividend of $0.138 per share on Ex-Date : April 10, 2024. Shareholders on record as of April 11, 2024 are eligible for the dividend. The payment date is scheduled for April 30, 2024, and the ...